Work

Airway inflammation enhances the effectiveness of elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis and CFTRN1303K mutation

Year: 2024

Type: article

Source: The Lancet Respiratory Medicine

DOI: 10.1016/s2213-2600(24)00305-9

Authors: Martina Gentzsch, Charles R Esther, Carla M P Ribeiro

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cystic Fibrosis Foundation, National Institute of Diabetes and Digestive and Kidney Diseases

OpenAlex ID: W4403259971

FWCI: 1.161

Cites: 5

Cited by: 4

Related to: 10